covid pfizer - Search News

News

mRNA, Rfk Jr. and Covid

RFK Jr cancels $500m in funding for mRNA vaccines for diseases like Covid

The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being developed to counter viruses that cause diseases such as the flu and Covid-19.

The Economic Times on MSN · 2h

As Covid cases rise in US, RKF Jr sparks uproar as he cancels half-billion dollar in funding for mRNA vaccines

The US Department of Health and Human Services has planned to cancel $500 million in funding for mRNA vaccines, citing potential risks and limited effectiveness against respiratory viruses. HHS Secretary Robert F.

USA TODAY on MSN · 1h

RFK Jr. to wind down $500M mRNA vaccine development

The U.S. Department of Health and Human Services said it would wind down mRNA vaccine development activities under its biomedical research unit.

Pfizer Raises Profit Outlook

Reuters on MSN · 17h

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

Wall Street Journal · 21h

Pfizer Raises Profit Outlook Despite Uncertainty Over Tariffs, Drug Prices

Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.

MarketWatch on MSN · 23h

Pfizer boosts profit estimate, even as the drug giant absorbs tariffs

Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart medication and its COVID-19 drugs.

Crain's New York Business19h

Pfizer lifts profit view as cuts offset flat sales outlook

Bourla, who took over as CEO in 2019, has declined to say how long he intends to remain in his role at Pfizer. Developing a ...

17hon MSN

Why Shares of Pfizer Soared Today

In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...

1d

Buy Pfizer Stock At $24?

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

1don MSN

Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

3hon MSN

1 Reason to Buy Pfizer (PFE) Stock

And better still, healthy and growing dividend-paying stocks tend to increase their payouts over time. Pfizer's total annual ...

2don MSN

Will health insurance pay for Covid vaccines this fall?

HHS Secretary Robert F. Kennedy Jr. has upended the way Covid vaccines are approved and for whom they’re recommended, ...

4don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Healthbeat on MSN2d

Sorting out Covid vaccine confusion: New and conflicting federal policies raise questions

If you want a Covid-19 shot this fall, will your employer’s health insurance plan pay for it? There’s no clear answer. But ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results